SCHEMBL4630355

SCHEMBL4630355

N#Cc1ccc(-c2ccc[c]c2C(N)=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.41
GRM2 Q14416 1/20 0.40
PARP2 Q9UGN5 2/20 0.40
PARP15 Q460N3 1/20 0.40
PARP10 Q53GL7 1/20 0.40
PARP1 P09874 3/20 0.39
CASP1 P29466 1/20 0.39
MYC P01106 2/20 0.37
MMP3 P08254 1/20 0.37
MAP4K4 O95819 1/20 0.36
MMP2 P08253 1/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA12 O43570 1/20 0.36
CA9 Q16790 1/20 0.36
CSF1R P07333 1/20 0.36
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
MAP2 P11137 1/20 0.35
EGLN2 Q96KS0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3097233 0.84 IKBKB (0.46) CSF1R
SCHEMBL2636302 0.80 BCAT2 (0.53) PARP1
SCHEMBL3462201 0.80 GRM2 (0.41) IRAK4GRM2MAP4K4
SCHEMBL3081965 0.80 MKNK1 (0.40) GRM2PARP1
SCHEMBL3659396 0.78 CYP11B2 (0.49) CYP11B1CYP11B2
SCHEMBL3660537 0.78 CNR2 (0.43) CYP11B2
SCHEMBL3653879 0.77 CDC7 (0.40) GRM2
SCHEMBL981626 0.76 FGFR1 (0.49) GRM2PARP2PARP10PARP1MAP4K4
SCHEMBL978717 0.75 PARP10 (0.50) PARP10
SCHEMBL3468427 0.75 GRM2 (0.48) IRAK4GRM2PARP2PARP15PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 EP claimed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO claimed
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 EP disclosed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO disclosed